Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-10, Stock:NVS, The news for the past five days is as follows:
2018-07-02: NEWS1: [$$] Novartis Injects Itself Into Planned Rollout of EpiPen Competitor.NEWS2: Novartis to Spin-Off Alcon as Separate Trading Company.NEWS3: Novartis to Spin-Off Alcon as Separate Trading Company.NEWS4: ADMP Abuzz, MESO Has A Blast, COOL Rebounds, BLFS Up Nearly 150% YTD.NEWS5: ADMP Abuzz, MESO Has A Blast, COOL Rebounds, BLFS Up Nearly 150% YTD.NEWS6: Novartis to Spin-Off Alcon as Separate Trading Company.NEWS7: Health Care Sector Update for 07/02/2018: ABBV,PRGO,TEVA,NVS,ADMP,MRK,AZN.NEWS8: Health Care Sector Update for 07/02/2018: ABBV,PRGO,TEVA,NVS,ADMP,MRK,AZN.NEWS9: Novartis Securities Investment Ltd -- Moody's downgrades Novartis' rating to A1; stable outlook.NEWS10: Adamis Pharma Shares Soar on Deal With Novartis for Epipen Competitor.NEWS11: Nordstrom may have trouble, Novartis signs distribution deal, Netflix buys LA billboards.NEWS12: Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion.NEWS13: Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion.NEWS14: After a year-long search, Adamis has a partner to market its EpiPen competitor.NEWS15: Nordstrom may have trouble according to analyst, Novartis signs distribution deal for EpiPen competitor, Netflix reportedly buys LA billboards.NEWS16: The Swiss Stock Market Pulled Back On Trade War Concerns.NEWS17: The Swiss Stock Market Pulled Back On Trade War Concerns.
2018-07-03: NEWS1: Adamis (ADMP) Surges Following Novartis Deal for Symjepi.NEWS2: Adamis (ADMP) Surges Following Novartis Deal for Symjepi.NEWS3: GlaxoSmithKline’s Valuation on June 29.NEWS4: Adamis (ADMP) Surges Following Novartis Deal for Symjepi.NEWS5: The Swiss Stock Markets Climbed On Strength Of Defensive Heavyweights.NEWS6: The Swiss Stock Markets Climbed On Strength Of Defensive Heavyweights.NEWS7: Adamis has a partner to market its EpiPen competitor after a year-long search.
2018-07-05: NEWS1: Key Developments from Ligand’s Partners Bode Well for It.NEWS2: How Novartis’s Segments Did in Q1 2018.NEWS3: 3 Best Biotech Acquisitions of 2018 (So Far).NEWS4: 3 Best Biotech Acquisitions of 2018 (So Far).NEWS5: Novartis’s Quarterly Revenue Trends and Estimates.NEWS6: 3 Best Biotech Acquisitions of 2018 (So Far).NEWS7: How Novartis’s Valuation Compares.NEWS8: The Swiss Stock Market Held On To A Small Gain After Late Sell-Off.NEWS9: The Swiss Stock Market Held On To A Small Gain After Late Sell-Off.
2018-07-06: NEWS1: Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs.NEWS2: Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs.NEWS3: Analyzing Novartis’s Alcon over Recent Quarters.NEWS4: Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs.NEWS5: How Novartis Stock Did in June.NEWS6: How Novartis’s Sandoz Has Performed.NEWS7: The Swiss Stock Market Clung To A Small Gain.NEWS8: The Swiss Stock Market Clung To A Small Gain.NEWS9: A Look at Novartis’s Innovative Medicines Business.
2018-07-09: NEWS1: Health Care Sector Update for 07/09/2018: MYL,NVS,BNTC,AXON,CYTX,SNGX.NEWS2: Health Care Sector Update for 07/09/2018: MYL,NVS,BNTC,AXON,CYTX,SNGX.NEWS3: [$$] China vows to accelerate cancer drug price cuts.NEWS4: The Swiss Stock Market Climbed As Trade Concerns Relax.NEWS5: The Swiss Stock Market Climbed As Trade Concerns Relax.NEWS6: What Analysts Recommend for Novartis Stock.

Answer: Decrease